A bibliometric analysis of HER2-positive breast cancer: 1987–2024

• DOI: 10.3389/fonc.2024.1355353
• Publication Date: 2024-05-01T04:30:36Z
• Authors: Sherlissa Ali-Tho...; Gordon R. Daly; Gavin P. Dowling; Conor Kilkenny; Luke Cox; Jason McGrath; Ma’en M. AlRawashdeh; Sindhuja Naidoo; Colm Power; Arnold D. K. Hill
• Keywords: HER2+; 0301 basic medicine; anti-HER2; trastuzumab; 03 medical and health sciences; breast cancer; bibliometric; Oncology; analysis; Neoplasms. Tumors. Oncology. Including cancer and carcinogens; RC254-282

The overamplification of human epidermal growth factor (HER2) in breast cancer (BC) has been the subject numerous research publications since its discovery 1987. This is first bibliometric analysis (BA) conducted on HER2-positive (HER2+) BC. purpose this BA to analyze published HER2+ BC from 1987 2024, highlighting most significant scientific literature, as well main contributing authors and journals, evaluating impact clinical lab-based research.